Jonathan L. Heeney

Infosys (India) — India

Immunology and Microbiology · Life Sciences

65h-index16.5kcitations423works2.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(215), Immune Cell Function and Interaction(88), SARS-CoV-2 and COVID-19 Research(65), T-cell and B-cell Immunology(52), Immunotherapy and Immune Responses(49)

Publications408 total

Efficacy and potential human and economic impact of a broadly protective betacoronavirus vaccine
2025Open Access
Serological evidence of SARS-CoV-2 infection in red and fallow deer in Great Britain
2025Open Access
Immunogenicity of a trivalent haemorrhagic fever vaccine candidate against Sudan virus, Marburg virus and Lassa virus in an mpox vaccine
Journal of General Virology·2025Open Access
Immunogenicity and Efficacy of Digitally Immune Optimised H1N1 Vaccine Candidates in Swine and Murine Animal Models
2025Open Access
Forecasting Lassa fever risk to enable smarter, targeted interventions
Journal of Interventional Epidemiology and Public Health·2025Open Access
Defining the pre-admission factors that modify risk of acute complications, survival and long-term recovery from COVID-19
2025Open Access
Computationally designed haemagglutinin with nanocage plug-and-display elicits pan-H5 influenza vaccine responses
Emerging Microbes & Infections·2025· 3 citedOpen Access
Digitally Immune-Optimised Next-Generation Influenza Vaccine Provides Cross-Clade Protection Against Emerging H5Nx Viruses
2025Open Access
Enhanced variant neutralization through glycan masking of SARS-CoV-2 XBB1.5 RBD
Emerging Microbes & Infections·2025Open Access
Covering All Bases: A Computational Method to Design Broad-spectrum T-cell-inducing Vaccines Applied to <i>Betacoronaviruses</i>
2025Open Access
Digitally Immune-Optimised Next-Generation Influenza H5Nx Vaccination Provides Protection with Broad Cross-Clade Neutralisation Against Global Threats
2025Open Access
Development of Pan-H5 Vaccines Against Avian Influenza Developed Using Computational Biology to Mitigate Future Pandemics
Journal of Allergy and Clinical Immunology·2025· 1 citedOpen Access
A Phase I, Needle Free, Dose Escalation Clinical Trial of pEVAC-PS, a Candidate Pan-Sarbecovirus Vaccine
SSRN Electronic Journal·2025Open Access
Digitally immune optimised haemagglutinin with nanocage plug-and-display elicits broadly neutralising pan-H5 influenza subtype vaccine responses
2024Open Access
Longitudinal effects of SARS-CoV-2 breakthrough infection on imprinting of neutralizing antibody responses
EBioMedicine·2024· 7 citedOpen Access
Computationally designed Spike antigens induce neutralising responses against the breadth of SARS-COV-2 variants
npj Vaccines·2024· 4 citedOpen Access
Global surveillance of emerging SARS-CoV-2 variants
Bulletin of the World Health Organization·2024· 4 citedOpen Access
Evolution of protective SARS-CoV-2-specific B and T cell responses upon vaccination and Omicron breakthrough infection
iScience·2024· 4 citedOpen Access
Immunological insights into COVID-19 in Southern Nigeria
Frontiers in Immunology·2024· 3 citedOpen Access
Replicative fitness and pathogenicity of primate lentiviruses in lymphoid tissue, primary human and chimpanzee cells: relation to possible jumps to humans
EBioMedicine·2024· 3 citedOpen Access
page 1 of 21Next →

Frequent Co-authors

Ernst J. Verschoor(7), Willy Bogers(5), Peter ten Haaft(5), Babs E. Verstrepen(4), Davide Corti(3), Sunita S. Balla-Jhagjhoorsingh(3), David A. Davis(3), Robin A. Weiss(3), Antonio Lanzavecchia(3), N. Parkinson(3), D. E. Stead(3), Petra Mooij(3), Christine S. Rollier(3), Rob Dubbes(3), Henk Niphuis(3), François Villinger(3), Fabrizia Vanzetta(2), David C. Montefiori(2), Federica Sallusto(2), Quentin J. Sattentau(2)